Kaneko, Keizo
Satake, Chihiro
Izumi, Tomohito
Tanaka, Mamiko
Yamamoto, Junpei
Asai, Yoichiro
Sawada, Shojiro
Imai, Junta
Yamada, Tetsuya
Katagiri, Hideki
Article History
Received: 27 August 2018
Accepted: 13 December 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: The need for ethics approval is deemed unnecessary by the Ethics Committee Tohoku University Graduate School of Medicine since this case report is not considered as a clinical study according to the ethical guideline.
: Written informed consent was obtained from the patient of this case report.
: Keizo Kaneko, Chihiro Satake, Tomohito Izumi, Mamiko Tanaka, Junpei Yamamoto and Yoichiro Asai have no potential conflicts of interest relevant to this article to report. Shojiro Sawada received honoraria for lectures from Sanofi K.K, Dainippon Sumitomo Pharma Co., Ltd., and Kowa Company, Ltd., Junta Imai received honoraria for lectures from Sanofi K.K, Sanwa Kagaku Kenkyusho Co., Ltd., Eli Lilly Japan K.K., Dainippon Sumitomo Pharma Co., Ltd., and Kowa Company, Ltd., and research grants from Eli Lilly Japan K.K. and Kowa Company, Ltd. Tetsuya Yamada received honoraria for lectures from Sanofi K.K, Sanwa Kagaku Kenkyusho Co., Ltd., Eli Lilly Japan K.K., Dainippon Sumitomo Pharma Co., Ltd., and Kowa Company, Ltd., and research grants from Sanofi K.K and Eli Lilly Japan K.K. Hideki Katagiri received honoraria for lectures from Sanofi K.K, Sanwa Kagaku Kenkyusho Co., Ltd., Eli Lilly Japan K.K., Dainippon Sumitomo Pharma Co., Ltd., and Kowa Company, Ltd., and research grants from Sanofi K.K, Sanwa Kagaku Kenkyusho Co., Ltd., Eli Lilly Japan K.K., Dainippon Sumitomo Pharma Co., Ltd., and Kowa Company, Ltd.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.